gree of ROP, as compared with 90% of infants with birth weight less than 750 grams. A similar pattern is seen for gestational age, ROP occurring in 30% of infants born at more than 31 weeks gestation and in 83% of infants born at less than 28 weeks gestation. 8 The awareness for screening and treatment for ROP has increased among both pediatricians and ophtalmologists since the last five years. However, in Indonesia there are no published reports of ROP and a screening guideline has not been established yet. Actually local criteria for each regional population and neonatal unit are required to determine the screening guideline. 4 Some less developed countries found that bigger, more mature infants develop threshold/ severe ROP. 9 In the Neonatology Division of Cipto Mangunkusumo Hospital, the screening of ROP has been performed routinely since December 2003 and we have found a case of ROP in an infant with birth weight 2500 grams and gestational age of 37 weeks who experienced severe sepsis. Consequently, the screening guideline in our unit is infants with birth weight 2500 grams or less and/or gestational age 37 weeks or less.
The aim of this study is to recognize the prevalence of ROP and its relation to several risk factors.
Methods
A cross-sectional descriptive study was conducted in the Neonatal Ward at Cipto Mangunkusumo Hospital from December 2003-May 2005. Inclusion criteria were infants with birth weight 2500 grams or less and/ or gestational age of 37 weeks or less who underwent ROP screening. Gestational age was assessed as completed weeks using obstetric estimates based on the date of the last menstrual period of the mother and confirmed by Ballard Method. The subjects were recruited consecutively.
The ophthalmic examination was initially performed by vitreoretina ophtalmologists at 4 to 6 weeks of chronological age or 31 to 33 weeks of postconceptional age. If no ROP was found, eye examinations were continued every one or two weeks until complete vascularization of retina, death, or discharge. Diagnosis and stage of ROP was classified by vitreoretina ophtalmologists according to International Classification of Retinopathy of Prematurity.
Risk factors related with ROP were recorded, such as birth weight, gestational age, sepsis, respiratory distress (not caused by sepsis), small for gestational age, asphyxia, apnea, multiple blood transfusions, and duration of oxygen therapy. The correlation between the stages of ROP with birth weight and gestational age was processed by Epi-Info.
Results
During the study period, 73 infants were enrolled and underwent ROP screening examination. The gestational age ranged from 27 to 40 weeks (median 33 weeks), birth weight ranged from 950 to 2500 grams (median 1600 grams). Three infants were full-term SGA infants, and 12 preterm SGA infants. There were 28 male infants and 45 female infants. Forty eight infants received oxygen therapy for more than 7 days, 20 infants less than 7 days, and 5 infants did not receive oxygen. Subject characteristics are shown in The birth weight groups ranged from 950 to 2100 grams (median: 1300±271.7 grams) and the gestational age ranged from 27 to 35 weeks (median: 32 ± 2.4 weeks). The non-ROP group had birth weight from 1000 to 2500 grams (median: 1700±354.5 grams), the gestational age ranged from 28 to 40 weeks (median: 34±2.5 weeks). Distribution of ROP and non-ROP group in relation with birth weight and gestational age is shown in Table 2 . Lower birth weight and younger gestational age were statistically significant in the development of ROP.
Severe ROP infants have birth weight from 1100 to 1600 grams (median: 1240±210.4 grams) and gestational age from 27 to 34 weeks (median: 30±2.6 weeks).
Stages of ROP was not correlated with lower birth weight PR 2.86 (CI 95% 0.96;8.47) and younger gestational age PR 1.71 (CI 95% 0.61;4.78) ( Table 3) .
Birth weight PR 6.650 (CI 95% 2.051; 21.563), sepsis PR 1.102 (CI 95% 1.012; 1.200), apneu PR 6.375 (CI 95% 1.857; 21.887), asphyxia PR 3.917 (CI 95% 1.1151; 13.326), multiple blood transfusions PR 4.350 (CI 95% 1.277; 14.820), and oxygen therapy for more than 7 days PR 0.159 (CI 95% 0.033; 0.756) were statistically significant with the development of ROP. However, from multivariate analysis alone, asphyxia, multiple blood transfusions, and oxygen therapy for more than 7 days were statistically significant with the development of ROP.
Discussion
The World Health Organization's Vision 2020 program targets ROP as an avoidable disease requiring early detection and treatment to prevent blindness. These strategies have successfully reduced the incidence of ROP, such as, routine fundus examination of premature neonates at less than 32 weeks gestation or under 1250 grams birth weight, provision of carefully monitored levels of supplemental oxygen, where necessary, and treatment by well trained and well equipped ophtalmologists. 3 Cryotherapy for retinopathy of prematurity multicenter study (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) reported that the incidence of ROP was 21.3% (202 out of 950 infants with gestational age less than 37 weeks). 10 Our study revealed that the prevalence of ROP was 26% (19 out of 73 patients) and the threshold RPP was 9.6% (7 out of 73 infants). The result was almost the same with Yang et al 2 in Taiwan 25% (27 out of 108 patients with birth weight less than 2000 grams or gestational age less than 36 weeks) and the threshold ROP was 7%.
In 2001, the American Academy of Pediatrics and the American Academy of Ophthamology have recommended screening in infants with birth weight less than 1500 grams and gestational age less than 28 weeks, with or without supplemental oxygen; or in clinically severe illness infants with birth weight 1500 to 2000 grams. 11, 12 Gilbert et al 9 showed that infants who develop severe ROP in highly developed countries differ from those who are affected in less well developed countries. Consequently, the screening guidelines are different in each country. In highly developed countries such as United States and United Kingdom, examinations are done in infants with birth weight less than 1500 grams or gestational age less than 32 weeks. However, some less developed countries widen their screening criteria, because bigger, more mature infants develop threshold ROP, for instance, India examines infants with birth weight less than 2000 grams or gestational age less than 35 weeks. 9 Our inclusion criteria for screening were different from other centers because yet there are no baseline data in Indonesia.
The CRYO-ROP multicenter study reported no ROP was noted in infants born at more than 32 weeks, and no severe ROP was noted in infants at more than 28 weeks of gestational age. 10 In our study, no ROP was noted in infants born at more than 35 weeks of gestational age and birth weight more than 2100 grams. No severe ROP was found in gestational age more than 34 weeks and birth weight more than 1600 grams. The discrepancy might be due to the differences in race and in systems applied by the neonatal unit of population studied. Our study, showed regional criteria for ROP screening is required. In the following year, our screening guideline may be altered to screen infants born at <34 weeks of gestational age and/or birth weight <1600 grams. Infants born with birth weight from 1600-< 2100 grams need to be screened only if supplemental oxygen is necessary; or in clinically severe illness with birth weight less than 2200 grams and/or gestational age less than 36 weeks. The guideline should be evaluated and modified periodically based on the evolving knowledge and advancements in neonatal care unit. 4 The pathogenesis of the development of ROP is still uncertain. Recent observation has found ROP to be a disease of multifactorial origin. 1, 6 The altered regulation of vascular endothelial growth factor (VEGF) has been suggested as one of the factors in the pathogenesis of ROP. In premature infants, the retina is incompletely vascularized. After premature birth, relative hyperoxia may downregulate VEGF production. Administration of supplemental oxygen may lead to sustained hyperoxia, setting the stage for vaso-obliteration of existing vessels and arrest of the vascularization. Over time, as the metabolic demands of the developing eye increases, the immature nonperfused area of the retina becomes hypoxic and may overproduce VEGF pathologically. High levels of VEGF stimulate neovascularization of the retina, which in severe cases may result in retinal fibrosis dan retinal detachment. 2, 3, 13 Sepsis in the low birth weight premature infants is frequently accompanied with hypotension which will impair tissue perfusion with local hypoxia to render retina under the risk of ROP development. Respiratory distress syndrome was known to be associated with systemic hypoxia, which will lead to retina ischemia. 2 Chronic hypoxia in utero and intrauterine growth retardation are two prenatal conditions that seem to be related to the development of ROP. 7, 8 In the current, study full-term SGA infants who received supplemental oxygen did not develop ROP, compared with 3 in 12 preterm SGA infants who did. Our study encouraged that in the low birth weight full-term infants it is unnecessary to undergo ROP screening.
It is hypothesized that the damaging effects of blood transfusions on the retina are mediated by an increase in free iron. Plasma non-transferrin boundfree iron was significantly increased in preterm infants after blood transfusion, but was not observed in fullterm infants after blood transfusion. 6, 14 High concentrations of oxygen therapy was previously thought as the major factor for the development of ROP. 2 However, some reports have found ROP may develop in premature infants who have received little or no supplemental oxygen. Even after oxygen therapy, not all premature infants develop ROP. These evidences suggested that risk factors other than oxygen might play an important role in the development of ROP. 3 As mentioned above, the repeated episodes of hyperoxia and hypoxia is important factor in the development of ROP. An oxygen management policy has to be implemented in the neonatal unit, such as a strict guideline in the practices of increasing and weaning fraction of inspired oxygen (FiO 2 ) and the monitoring of oxygen saturation (SpO 2 ). 1, 3 In our study, we only recorded the duration of oxygen therapy because monitoring of SpO 2 just could have been implemented in our unit since 2004. Our findings urged us to make strict guidelines in the practice of increasing or weaning of oxygen therapy and the monitoring of oxygen saturation. The guideline includes curtail unnecessary O 2 administration, prevent abrupt changes in O 2 saturation, maintain certain O 2 saturation according to gestational age. 5, 14 Birth weight, gestational age, duration of ventilation therapy, blood transfusion, respiratory distress syndrome, and sepsis were reported previously to be associated with increased risk of ROP (as citated from Ikeda). 6 Yang et al 2 reported low birth weight and young gestational age are the most important risk factors in the development of ROP. Our study showed that birth weight, sepsis, apneu, asphyxia, multiple blood transfusions, and oxygen therapy of more than 7 days were statistically significant with the development of ROP. However, using multivariate analysis, only asphyxia, multiple blood transfusions and oxygen therapy for more than 7 days were statistically significant with the development of ROP.
Yang et al 2 showed that there was a correlation between severity of ROP with lower birth weight and younger gestational age. It was different from our study, may be because survival of extremely preterm infants and extremely very low birth weight in our unit was low.
We concluded that asphyxia, multiple blood transfusions, and oxygen therapy for more than 7 days are the most important risk factors in the development of ROP. The screening guideline should be evaluated and modified periodically based on the evolving knowledge and the advancements in neonatal care unit. The low birth weight full-term infants should not necessarily undergo ROP screening.
